Disclosure of Payments to Healthcare Professionals
Our collaborations with healthcare professionals always aim to benefit patients, improve medical practices and patient care.
Activities can range from clinical research to exchanges on how new medicines fit into patient pathway.
We believe that a more open transparent relationship strengthens the basis for collaboration and is in the best interest of patients and all health stakeholders.
For this reason, we are committed to disclose our interactions with healthcare professionals and organizations through the Disclosure Code de l’EFPIA.
Austria
Public disclosure 2019, 2020, 2021,
Belgium
Bulgaria
Public disclosure 2019, 2020, 2021
Cyprus
Public disclosure 2019, 2021,
No Transfer of Value in 2020
Czech Republic
No Transfer of Value in 2020
Denmark
Public disclosure 2019, 2020, 2021
Estonia
No Transfer of Value in 2019, 2020, 2021
Finland
Public disclosure 2019, 2020, 2021,
France
Germany
Greece
Greece PFD report 2019/Greece PFMS report 2019/ Pierre Fabre Greek Crossborder ToVs 2019
Report PFD 2020/ Report PFMS 2020/
PFMS Italy Greek Crossborder 2020 /Pierre Fabre Corporate Greek Crossborder 2020
Greece PFD report 2021/Greece PFMS report 2021/ Pierre Fabre Greek Crossborder ToVs 2021
Hungary
Public disclosure 2019, 2021
No Transfer of Value in 2020
Italy
Ireland
Lithuania
No Transfer of Value in 2019, 2020,2021
Malta
No Transfer of Value in 2019, 2020, 2021
Netherlands
Norway
Public disclosure 2019, 2020, 2021
Poland
Public disclosure HCP 2019, 2020, 2021
Public disclosure HCO 2019, 2020, 2021
Public disclosure R&D 2019, 2020 , 2021
Portugal
Romania
No Transfer of Value in 2019, 2020, 2021
Russia
Slovak republic
Public disclosure 2019, 2020, 2021
Spain
Sweden
Public disclosure 2019, 2020, 2021
Switzerland
Public disclosure 2019, 2020, 2021
Ukraine
No Transfer of Value in 2019, 2020, 2021
United Kingdom
DISCLOSURE METHODOLOGY PIERRE FABRE PHARMACEUTICALS TOV 2021
- The publication provided through this section is made in accordance with the Company Self-Certification.
- Following European legislation on data privacy, recipients of published transfers of value have a right to access and correct personal data concerning them, which is exercisable by e-mail: transparency.compliance@pierre-fabre.com